This website might not be available on Saturday, 21 September 2019, between 08:00 IRST and 18:00 IRST, due to maintenance.
J Dent Res Dent Clin Dent Prospects. 2017;11(3):135-139.
doi: 10.15171/joddd.2017.025
PMID: 29184627
PMCID: PMC5666211
  Abstract View: 1041
  PDF Download: 1238
  Full Text View: 379

Basic Research

Medical sequencing of de novo ectodermal dysplasia in identical twins and evaluation of the potential eligibility for recombinant EDA therapy

Adriana Modesto 1,2 * , Catherine Ventura 1, Kathleen Deeley 2, Deborah Studen-Pavlovich 1, Alexandre Rezende Vieira 1,2

1 University of Pittsburgh School of Dental Medicine, Department of Pediatric Dentistry, Pittsburgh, PA, USA
2 University of Pittsburgh School of Dental Medicine, Department of Oral Biology, Pittsburgh, PA, USA


The purpose of this study was to test two 8-year-old identical twins with ectodermal dysplasia (ED) and their unaffected parents for the presence of mutations in the EDA gene with the hypothesis that they might be carrying a de novo mutation in EDA and potentially eligible for recombinant EDA therapy. DNA was extracted using saliva samples obtained from the identical twin girls and both parents. PCR products of Ectodyplasin A (EDA), Ectodysplasin Receptor (EDAR), Ectodysplasin Receptor Associated Death Domain (EDARADD), and Connexin-30 (GJB6) were sequenced by the Sanger method and the results analyzed using a reference sequence. Exons and exon-intron boundaries of EDA, EDAR, EDARADD, and GJB6 were sequenced in both parents and the affected identical twin pair. No mutations were detected in EDA or GJB6. Genetic variants located in the intron of EDAR were found but determined to be non-contributory to the twins’ ED. A microsatellite polymorphism was detected in all four subjects in exon 4 of the EDARADD gene but determined not to be causal to the ED. There was a silent mutation detected in exon 6 of the EDARADD gene of both the daughters and their unaffected mother but also unlikely to be the cause of ED. These results suggest that ED of the subjects is caused by a de novo mutation in a gene not studied here. It is likely these subjects and their future offspring would not benefit from the development of recombinant EDA replacement therapy.
First name
Last name
Email address
Security code

Article Viewed: 1041

Your browser does not support the canvas element.

PDF Downloaded: 1238

Your browser does not support the canvas element.

Full Text Viewed: 379

Your browser does not support the canvas element.

Submitted: 18 Aug 2017
Accepted: 20 Aug 2017
First published online: 20 Aug 2017
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)